Kyowa Kirin Co., Ltd.

4151.T · Moat type: REGULIERUNG

MoatScore

4/10

Fair Value

2,135 JPY (≈ 13.24 USD)

Margin of Safety

-23.6 %

Rating

BEOBACHTEN

Kyowa Kirin is a Japanese specialty pharmaceutical company that focuses on the development and marketing of antibody-based biologics and specialty medicines in the fields of nephrology, oncology, and immunology, with revenue generated primarily through patent-protected products with regulatory market-entry barriers.

View full analysis →

🔒 Detailed AI analysis, peer comparison, capital allocation, crisis resilience & PDF report for Pro members.

Not investment advice. Analyses are research, not a recommendation. Valuations may be erroneous or incomplete. © MoatScan.ai — proprietary methodology.